Page last updated: 2024-10-27

flecainide and Gelineau Syndrome

flecainide has been researched along with Gelineau Syndrome in 1 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Research Excerpts

ExcerptRelevanceReference
"Modafinil is a non-amphetaminic wake-promoting compound used as therapy against sleepiness and narcolepsy."3.83Impact of Astroglial Connexins on Modafinil Pharmacological Properties. ( Charvériat, M; Chauveau, F; Dauvilliers, Y; Duchêne, A; Giaume, C; Jeanson, T; Lagarde, D; Lin, JS; Liu, X; Mouthon, F; Perier, M; Picoli, C; Piérard, C; Thomasson, J; Zhao, Y, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duchêne, A1
Perier, M1
Zhao, Y1
Liu, X1
Thomasson, J1
Chauveau, F1
Piérard, C1
Lagarde, D1
Picoli, C1
Jeanson, T1
Mouthon, F1
Dauvilliers, Y1
Giaume, C1
Lin, JS1
Charvériat, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Therapeutic Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation in Healthy Subjects[NCT03182413]Phase 120 participants (Actual)Interventional2015-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for flecainide and Gelineau Syndrome

ArticleYear
Impact of Astroglial Connexins on Modafinil Pharmacological Properties.
    Sleep, 2016, 06-01, Volume: 39, Issue:6

    Topics: Animals; Astrocytes; Benzhydryl Compounds; Connexin 30; Connexin 43; Connexins; Disease Models, Anim

2016